{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:48:59Z","timestamp":1771303739150,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1007\/bf03343992","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T11:03:44Z","timestamp":1394535824000},"page":"208-213","source":"Crossref","is-referenced-by-count":69,"title":["Relation of three polymorphisms of the CTLA-4 gene in patients with Graves\u2019 disease"],"prefix":"10.1007","volume":"25","author":[{"given":"T.","family":"Kouki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Gardine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J.","family":"DeGroot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343992_CR1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/cs0930479","volume":"93","author":"J Heward","year":"1997","unstructured":"Heward J., Gough S.C. Genetic susceptibility to the development of autoimmune disease. Clin. Science 1997, 93: 479\u2013491.","journal-title":"Clin. Science"},{"key":"BF03343992_CR2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/edrv-10-4-537","volume":"10","author":"LJ DeGroot","year":"1989","unstructured":"DeGroot L.J., Quintans J. The causes of autoimmune thyroid disease. Endocr. Rev. 1989, 10: 537\u2013562.","journal-title":"Endocr. Rev."},{"key":"BF03343992_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2265.1980.tb03421.x","volume":"13","author":"NR Farid","year":"1980","unstructured":"Farid N.R., Stone E., Johnson G. Graves\u2019 disease and HLA: clinical and epidemiologic associations. Clin. Endocrinol. (Oxf.) 1980, 13: 535\u2013544.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343992_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2265.1991.tb00309.x","volume":"34","author":"N Tandon","year":"1991","unstructured":"Tandon N., Zhang L., Weetman A.P. HLA associations with Hashimoto\u2019s thyroiditis. Clin. Endocrinol. (Oxf.) 1991, 34: 383\u2013386.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03343992_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-065X.1996.tb00919.x","volume":"153","author":"CA Chambers","year":"1996","unstructured":"Chambers C.A., Krummel M.F., Boitel B., et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 1996, 153: 27\u201346.","journal-title":"Immunol. Rev."},{"key":"BF03343992_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0952-7915(99)80047-8","volume":"11","author":"MA Oosterwegel","year":"1999","unstructured":"Oosterwegel M.A., Greenwald R.J., Mandelbrot D.A., et al. CTLA-4 and T cell activation. Curr. Opin. Immunol. 1999, 11: 294\u2013300.","journal-title":"Curr. Opin. Immunol."},{"key":"BF03343992_CR7","doi-asserted-by":"crossref","first-page":"8670","DOI":"10.1073\/pnas.94.16.8670","volume":"94","author":"F Colucci","year":"1997","unstructured":"Colucci F., Bergman M.L., Penha-Goncalves C., et al. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. USA. 1997, 94: 8670\u20138674.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BF03343992_CR8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/1074-7613(95)90125-6","volume":"3","author":"EA Tivol","year":"1995","unstructured":"Tivol E.A., Borriello F., Schweitzer A.N., et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995, 3: 541\u2013547.","journal-title":"Immunity"},{"key":"BF03343992_CR9","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.270.5238.985","volume":"270","author":"P Waterhouse","year":"1995","unstructured":"Waterhouse P., Penninger J.M., Timms E., et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995, 270: 985\u2013988.","journal-title":"Science"},{"key":"BF03343992_CR10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/bbrc.1996.1256","volume":"225","author":"K Deichmann","year":"1996","unstructured":"Deichmann K., Heinzmann A., Bruggenolte E., et al. An Mse 1 RFLP in the human CTLA-4 promotor. Biochem. Biophys. Res. Commun. 1996, 225: 817\u2013818.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03343992_CR11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.147.3.1037","volume":"147","author":"K Harper","year":"1991","unstructured":"Harper K., Balzano C., Rouvier E., et al. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 1991, 147: 1037\u20131044.","journal-title":"J. Immunol."},{"key":"BF03343992_CR12","doi-asserted-by":"crossref","unstructured":"Polymeropoulos M.H., Xiao H., Rath D.S., et al. Dinucleotide repeat polymorphism at the human CTLA-4 gene. 1991, 19: 4018.","DOI":"10.1093\/nar\/19.14.4018-a"},{"key":"BF03343992_CR13","first-page":"41","volume":"80","author":"T Yanagawa","year":"1995","unstructured":"Yanagawa T., Hidaka Y., Guimaraes V., et al. CTLA-4 gene polymorphism associated with Graves\u2019 disease in a Caucasian population. J. Clin. Endocrinol. Metab. 1995, 80: 41\u201345.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343992_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(99)00072-7","volume":"97","author":"A Ligers","year":"1999","unstructured":"Ligers A., Xu C., Saarinen S., Hiliert J., et al. The CTLA-4 gene is associated with multiple sclerosis J. Neuroimmunol. 1999, 97: 182\u2013190.","journal-title":"J. Neuroimmunol."},{"key":"BF03343992_CR15","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1055\/s-0029-1212159","volume":"107","author":"K Badenhoop","year":"1999","unstructured":"Badenhoop K., Donner H., Pani M., et al. Genetic susceptibility to Type 1 diabetes: clinical and molecular heterogeneity of IDDM1 and IDDM12 in a German population. Exp. Clin. Endocrinol. Diabetes 1999, 107: S89\u2013S92.","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"BF03343992_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/genetics\/49.1.49","volume":"49","author":"RC Lewontin","year":"1964","unstructured":"Lewontin R.C. The interaction of selection and linkage. I. General consideration; heterotic models. Genetics 1964, 49: 49\u201367.","journal-title":"Genetics"},{"issue":"Suppl.4","key":"BF03343992_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000191314","volume":"48","author":"AP Weetman","year":"1997","unstructured":"Weetman A.P. New aspects of thyroid immunity. Horm. Res. 1997, 48 (Suppl. 4): 51\u201354.","journal-title":"Horm. Res."},{"key":"BF03343992_CR18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1399-0039.1998.tb02993.x","volume":"51","author":"J Braun","year":"1998","unstructured":"Braun J., Donner H., Siegmund T., et al. CTLA-4 promoter variants in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Tissue Antigens 1998, 51: 563\u2013566.","journal-title":"Tissue Antigens"},{"key":"BF03343992_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2265.1998.00542.x","volume":"49","author":"JM Heward","year":"1998","unstructured":"Heward J.M., Allahabadia A., Carr-Smith J., et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin. Endocrinol. 1998, 49: 331\u2013334.","journal-title":"Clin. Endocrinol."},{"key":"BF03343992_CR20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-0039.1999.530311.x","volume":"53","author":"MF Gonzalez-Escribano","year":"1999","unstructured":"Gonzalez-Escribano M.F., Rodriguez R., Valenzuela A., et al. CTLA-4 polymorphisms in Spanish patients with rheumatoid arthritis. Tissue Antigens 1999, 53: 296\u2013300.","journal-title":"Tissue Antigens"},{"key":"BF03343992_CR21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1399-0039.1999.530112.x","volume":"53","author":"HF Harbo","year":"1999","unstructured":"Harbo H.F., Celius E.G, Vartdal F., et al. CTLA-4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 1999, 53: 106\u2013110.","journal-title":"Tissue Antigens"},{"key":"BF03343992_CR22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","volume":"5","author":"L Nistico","year":"1996","unstructured":"Nistico L., Buzzetti R., Pritchard L.E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with Type 1 diabetes. Human Mol. Genet. 1996, 5: 1075\u20131080.","journal-title":"Human Mol. Genet."},{"key":"BF03343992_CR23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1073\/pnas.83.6.1670","volume":"83","author":"D Caput","year":"1986","unstructured":"Caput D., Beutler B., Hartog K., et al. Identification of a common nucleotide sequence in the 3\u2032-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 1986, 83: 1670\u20131674.","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"BF03343992_CR24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0092-8674(86)90341-7","volume":"46","author":"G Shaw","year":"1986","unstructured":"Shaw G., Kamen R. A conserved AU sequence from the 3\u2032 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986, 46: 659\u2013667.","journal-title":"Cell"},{"key":"BF03343992_CR25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0168-9525(96)10016-0","volume":"12","author":"J Ross","year":"1996","unstructured":"Ross J. Control of messenger RNA stability in higher eukaryotes. Trends Genetics 1996, 12: 171\u2013175.","journal-title":"Trends Genetics"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343992\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T02:36:09Z","timestamp":1689042969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["BF03343992"],"URL":"https:\/\/doi.org\/10.1007\/bf03343992","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}